The level of AKT activation in MIA-PaCa-2 is well below that of the human prostate cancer cell line LNCaP, which harbours a PTEN mutation and thus has high levels of PI3K activity (Davies et al, 1999). This evidence concerns the gene AKT1 and prostate carcinoma.